Rhythm Pharmaceuticals (RYTM) Work In Process (2023 - 2025)

Rhythm Pharmaceuticals (RYTM) has 3 years of Work In Process data on file, last reported at $387000.0 in Q3 2025.

• Work In Process for Q3 2025 came in at $387000.0, down 53.93% year-over-year; the trailing twelve-month figure through Sep 2025 was $387000.0 (down 53.93% YoY), and the FY2024 annual result was $1.2 million, up 13.22% from the prior year.
• Work In Process slipped to $387000.0 in Q3 2025 per RYTM's latest filing, from $767000.0 in the prior quarter.
• Over five years, Work In Process peaked at $3.5 million in Q3 2023 and troughed at $387000.0 in Q3 2025.
• A 3-year average of $1.7 million and a median of $1.5 million in 2024 frame the typical range for Work In Process.
• On a YoY basis, Work In Process climbed as much as 13.22% in 2024 and fell as far as 75.99% in 2024.
• A 3-year view of Work In Process shows it stood at $1.1 million in 2023, then advanced by 13.22% to $1.2 million in 2024, then tumbled by 69.04% to $387000.0 in 2025.
• Business Quant data shows RYTM's Work In Process at $387000.0 in Q3 2025, $767000.0 in Q2 2025, and $1.7 million in Q1 2025.